These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1252 related items for PubMed ID: 26277091

  • 21. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 22. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP.
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L, Rosenqvist M, Lip GY.
    Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
    [Abstract] [Full Text] [Related]

  • 24. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
    O'Brien EC, Simon DN, Thomas LE, Hylek EM, Gersh BJ, Ansell JE, Kowey PR, Mahaffey KW, Chang P, Fonarow GC, Pencina MJ, Piccini JP, Peterson ED.
    Eur Heart J; 2015 Dec 07; 36(46):3258-64. PubMed ID: 26424865
    [Abstract] [Full Text] [Related]

  • 25. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, Gallinghouse GJ, Themistoclakis S, Rossillo A, Lakkireddy D, Reddy M, Hao S, Hongo R, Beheiry S, Zagrodzky J, Rong B, Mohanty S, Elayi CS, Forleo G, Pelargonio G, Narducci ML, Dello Russo A, Casella M, Fassini G, Tondo C, Schweikert RA, Natale A.
    Circulation; 2014 Jun 24; 129(25):2638-44. PubMed ID: 24744272
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Atrial fibrillation incrementally increases dementia risk across all CHADS2 and CHA2DS2VASc strata in patients receiving long-term warfarin.
    Graves KG, May HT, Jacobs V, Bair TL, Stevens SM, Woller SC, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Peter Weiss J, Jared Bunch T.
    Am Heart J; 2017 Jun 24; 188():93-98. PubMed ID: 28577686
    [Abstract] [Full Text] [Related]

  • 28. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S, Bennett D, Smith DJ.
    Am J Cardiovasc Drugs; 2010 Jun 24; 10(1):37-48. PubMed ID: 20104933
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillation.
    Søgaard M, Ording AG, Skjøth F, Larsen TB, Nielsen PB.
    Eur Heart J Cardiovasc Pharmacother; 2024 Feb 23; 10(2):137-146. PubMed ID: 37993415
    [Abstract] [Full Text] [Related]

  • 31. Underutilization of warfarin for stroke prophylaxis in patients with atrial fibrillation or atrial flutter in Korea.
    Lee IH, Kim H, Je NK.
    J Cardiol; 2015 Dec 23; 66(6):475-81. PubMed ID: 26242197
    [Abstract] [Full Text] [Related]

  • 32. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
    Wysokinski WE, McBane RD, Daniels PR, Litin SC, Hodge DO, Dowling NF, Heit JA.
    Mayo Clin Proc; 2008 Jun 23; 83(6):639-45. PubMed ID: 18533080
    [Abstract] [Full Text] [Related]

  • 33. Lower rate of major bleeding in very high risk patients undergoing left atrial appendage occlusion: A propensity score-matched comparison with direct oral anticoagulant.
    Magnocavallo M, Della Rocca DG, Vetta G, Mohanty S, Gianni C, Polselli M, Rossi P, Parlavecchio A, Fazia MV, Guarracini F, De Vuono F, Bisignani A, Pannone L, Raposeiras-Roubín S, Lochy S, Cauti FM, Burkhardt JD, Boveda S, Sarkozy A, Sorgente A, Bianchi S, Chierchia GB, de Asmundis C, Al-Ahmad A, Di Biase L, Horton RP, Natale A.
    Heart Rhythm; 2024 Aug 23; 21(8):1267-1276. PubMed ID: 38246567
    [Abstract] [Full Text] [Related]

  • 34. Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation.
    Park YK, Lee MJ, Kim JH, Lee JS, Park RW, Kim GM, Chung CS, Lee KH, Kim JS, Lee SY, Bang OY.
    J Stroke Cerebrovasc Dis; 2017 Jun 23; 26(6):1383-1390. PubMed ID: 28412319
    [Abstract] [Full Text] [Related]

  • 35. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN, Lip GY, Kamper AL, Hansen PR, Lamberts M, Hommel K, Hansen ML, Gislason GH, Torp-Pedersen C, Olesen JB.
    J Am Coll Cardiol; 2014 Dec 16; 64(23):2471-82. PubMed ID: 25500231
    [Abstract] [Full Text] [Related]

  • 36. Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.
    Overvad TF, Larsen TB, Albertsen IE, Rasmussen LH, Lip GY.
    Expert Rev Cardiovasc Ther; 2013 Dec 16; 11(12):1619-29. PubMed ID: 24215192
    [Abstract] [Full Text] [Related]

  • 37. Left Atrial Enlargement and Anticoagulation Status in Patients with Acute Ischemic Stroke and Atrial Fibrillation.
    Dakay K, Chang AD, Hemendinger M, Cutting S, McTaggart RA, Jayaraman MV, Chu A, Panda N, Song C, Merkler A, Gialdini G, Kummer B, Lerario MP, Kamel H, Elkind MSV, Furie KL, Yaghi S.
    J Stroke Cerebrovasc Dis; 2018 Jan 16; 27(1):192-197. PubMed ID: 28918087
    [Abstract] [Full Text] [Related]

  • 38. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A, Clementy N, Haguenoer K, Fauchier L, Lip GY.
    Am J Med; 2014 Oct 16; 127(10):972-8. PubMed ID: 24929021
    [Abstract] [Full Text] [Related]

  • 39. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
    Guo Y, Lip GY, Apostolakis S.
    Hosp Pract (1995); 2013 Feb 16; 41(1):71-8. PubMed ID: 23466969
    [Abstract] [Full Text] [Related]

  • 40. Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.
    Steinberg BA, Greiner MA, Hammill BG, Curtis LH, Benjamin EJ, Heckbert SR, Piccini JP.
    Cardiovasc Ther; 2015 Aug 16; 33(4):177-83. PubMed ID: 25930214
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 63.